RXST Relative Valuation
RXST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RXST is overvalued; if below, it's undervalued.
Historical Valuation
Rxsight Inc (RXST) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -27.52. The fair price of Rxsight Inc (RXST) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：12.08
Fair
-10.65
PE
1Y
3Y
5Y
Trailing
Forward
-5.40
EV/EBITDA
Rxsight Inc. (RXST) has a current EV/EBITDA of -5.40. The 5-year average EV/EBITDA is -26.96. The thresholds are as follows: Strongly Undervalued below -86.37, Undervalued between -86.37 and -56.67, Fairly Valued between 2.74 and -56.67, Overvalued between 2.74 and 32.45, and Strongly Overvalued above 32.45. The current Forward EV/EBITDA of -5.40 falls within the Historic Trend Line -Fairly Valued range.
-5.04
EV/EBIT
Rxsight Inc. (RXST) has a current EV/EBIT of -5.04. The 5-year average EV/EBIT is -20.29. The thresholds are as follows: Strongly Undervalued below -62.05, Undervalued between -62.05 and -41.17, Fairly Valued between 0.59 and -41.17, Overvalued between 0.59 and 21.46, and Strongly Overvalued above 21.46. The current Forward EV/EBIT of -5.04 falls within the Historic Trend Line -Fairly Valued range.
3.90
PS
Rxsight Inc. (RXST) has a current PS of 3.90. The 5-year average PS is 8.17. The thresholds are as follows: Strongly Undervalued below 1.01, Undervalued between 1.01 and 4.59, Fairly Valued between 11.74 and 4.59, Overvalued between 11.74 and 15.32, and Strongly Overvalued above 15.32. The current Forward PS of 3.90 falls within the Undervalued range.
-47.57
P/OCF
Rxsight Inc. (RXST) has a current P/OCF of -47.57. The 5-year average P/OCF is 508.72. The thresholds are as follows: Strongly Undervalued below -3743.21, Undervalued between -3743.21 and -1617.25, Fairly Valued between 2634.68 and -1617.25, Overvalued between 2634.68 and 4760.65, and Strongly Overvalued above 4760.65. The current Forward P/OCF of -47.57 falls within the Historic Trend Line -Fairly Valued range.
-25.32
P/FCF
Rxsight Inc. (RXST) has a current P/FCF of -25.32. The 5-year average P/FCF is -72.83. The thresholds are as follows: Strongly Undervalued below -378.89, Undervalued between -378.89 and -225.86, Fairly Valued between 80.20 and -225.86, Overvalued between 80.20 and 233.23, and Strongly Overvalued above 233.23. The current Forward P/FCF of -25.32 falls within the Historic Trend Line -Fairly Valued range.
Rxsight Inc (RXST) has a current Price-to-Book (P/B) ratio of 1.77. Compared to its 3-year average P/B ratio of 5.90 , the current P/B ratio is approximately -70.09% higher. Relative to its 5-year average P/B ratio of 4.83, the current P/B ratio is about -63.43% higher. Rxsight Inc (RXST) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.21%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -8.04% , the current FCF yield is about -100.00% lower.
1.86
P/B
Median3y
5.90
Median5y
4.83
-4.55
FCF Yield
Median3y
-5.21
Median5y
-8.04
Competitors Valuation Multiple
The average P/S ratio for RXST's competitors is , providing a benchmark for relative valuation. Rxsight Inc Corp (RXST) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -14.09%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of RXST decreased by 63.67% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -17.95 to -32.35.
The secondary factor is the Revenue Growth, contributed -14.09%to the performance.
Overall, the performance of RXST in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Rxsight Inc (RXST) currently overvalued or undervalued?
What is Rxsight Inc (RXST) fair value?
How does RXST's valuation metrics compare to the industry average?
What is the current P/B ratio for Rxsight Inc (RXST) as of Dec 05 2025?
What is the current FCF Yield for Rxsight Inc (RXST) as of Dec 05 2025?
What is the current Forward P/E ratio for Rxsight Inc (RXST) as of Dec 05 2025?